CBOE Holdings Inc.

05/15/2019 | Press release | Distributed by Public on 05/15/2019 07:39

Turning Point Therapeutics Reports FDA Clearance Of Investigational New Drug Application for TPX-0022

Cboe - Market News Story

Turning Point Therapeutics Reports FDA Clearance Of Investigational New Drug Application for TPX-0022

Benzinga Newsdesk 5/15/2019 8:03:26 AM